Cargando…

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date

Relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) is associated with a poor prognosis in both children and adults. Traditionally, there were limited options for salvage therapy, which consisted mostly of conventional chemotherapy. However, in the past 5 years, novel agents have changed ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hathaway, Lindsey, Sen, Jeremy Michael, Keng, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173178/
https://www.ncbi.nlm.nih.gov/pubmed/30323696
http://dx.doi.org/10.2147/PROM.S149420

Ejemplares similares